A Study of the Efficacy and Safety of Topiramate Treatment in Patients With Epilepsy

NCT00266591 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy
Seizures

Interventions

DRUG: topiramate

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.